fluconazolesusceptibel
Fluconazolesusceptibel is a neologism used in clinical microbiology to describe fungal isolates that meet established criteria for susceptibility to fluconazole as determined by in vitro antifungal susceptibility testing. It denotes a label indicating that, under standard conditions and dosing, fluconazole is expected to inhibit growth of the organism and support clinical response, acknowledging that patient factors and infection site may influence outcome.
Susceptibility is assessed by testing methods such as broth microdilution, agar diffusion, or commercial panels, with
Clinical implications include aiding in the selection of antifungal therapy and stewardship; however, in vitro susceptibility